Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia

References

• Fuchs S., Baffour R., Zhou Y. F., Shou M., Pierre A., Tio F. O., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001; 37: 1726–32
   PubMed Web of Science ®Google Scholar
• Silva G. V., Litovsky S., Assad J. A., Sousa A. L., Martin B. J., Vela D., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150–6
   PubMed Web of Science ®Google Scholar
• Tomita S., Mickle D. A., Weisel R. D., Jia Z. Q., Tumiati L. C., Allidina Y., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002; 123: 1132–40
   PubMed Web of Science ®Google Scholar
• Kocher A. A., Schuster M. D., Szabolcs M. J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone‐marrow‐derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430–6
   PubMed Web of Science ®Google Scholar
• Schachinger V., Assmus B., Britten M. B., Honold J., Lehmann R., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one‐year results of the TOPCARE‐AMI Trial. J Am Coll Cardiol 2004; 44: 1690–9
   PubMed Web of Science ®Google Scholar
• Dobert N., Britten M., Assmus B., Berner U., Menzel C., Lehmann R., et al. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG‐PET and thallium SPECT. Eur J Nucl Med Mol Imaging 2004; 31: 1146–51
   PubMed Web of Science ®Google Scholar
• Fernandez‐Aviles F., San Roman J. A., Garcia‐Frade J., Fernandez M. E., Penarrubia M. J., de la Fuente, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742–8
   PubMed Web of Science ®Google Scholar
• Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., et al. Intracoronary injection of CD133‐positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005; 112: I178–83
   PubMed Web of Science ®Google Scholar
• Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow‐derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210–21
   PubMed Web of Science ®Google Scholar
• Strauer B. E., Brehm M., Zeus T., Bartsch T., Schannwell C., Antke C., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005; 46: 1651–8
   PubMed Web of Science ®Google Scholar
• Beeres S. L., Bax J. J., Kaandorp T. A., Zeppenfeld K., Lamb H. J., Dibbets‐Schneider P., et al. Usefulness of intramyocardial injection of autologous bone marrow‐derived mononuclear cells in patients with severe angina pectoris and stress‐induced myocardial ischemia. Am J Cardiol 2006; 97: 1326–31
   PubMed Web of Science ®Google Scholar
• Beeres S. L., Bax J. J., Dibbets‐Schneider P., Stokkel M. P., Fibbe W. E., van der Wall E. E., et al. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve‐month follow‐up results. Am Heart J 2006; 152: 684–6
   PubMedGoogle Scholar
• Kang H. J., Kim H. S., Zhang S. Y., Park K. W., Cho H. J., Koo B. K., et al. Effects of intracoronary infusion of peripheral blood stem‐cells mobilised with granulocyte‐colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004; 363: 751–6
   PubMed Web of Science ®Google Scholar
• Perin E. C., Dohmann H. F., Borojevic R., Silva S. A., Sousa A. L., Silva G. V., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004; 110: II213–8
   PubMed Web of Science ®Google Scholar
• Ben Haim S. A., Osadchy D., Schuster I., Gepstein L., Hayam G., Josephson M. E. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996; 2: 1393–5
   PubMedGoogle Scholar
• Gepstein L., Hayam G., Ben Haim S. A. A novel method for nonfluoroscopic catheter‐based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 1997; 95: 1611–22
   PubMed Web of Science ®Google Scholar
• Perin E. C., Dohmann H. F., Borojevic R., Silva S. A., Sousa A. L., Mesquita C. T., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294–302
   PubMed Web of Science ®Google Scholar
• Austen W. G., Edwards J. E., Frye R. L., Gensini G. G., Gott V. L., Griffith L. S., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5–40
   PubMedGoogle Scholar
• Reiber J. H. C., Schiemanck L. R., van der Zwet P. M. J., Goedhart B., Koning G., Lammertsma M. State of the art in quantative coronary arteriography as of 1996. Cardiovascular imaging, J. H. C Reiber, P. W Serruys. Kluwer Academic Publishers, Dordrecht 1996; 39–56
   Google Scholar
• Hamsten A., Walldius G., Szamosi A., Dahlen G., de Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 1986; 73: 1097–110
   PubMed Web of Science ®Google Scholar
• Lamb H. J., Doornbos J., van der Velde E. A., Kruit M. C., Reiber J. H., de Roos A. Echo planar MRI of the heart on a standard system: validation of measurements of left ventricular function and mass. J Comput Assist Tomogr 1996; 20: 942–9
   PubMed Web of Science ®Google Scholar
• Van der Geest R. J., Buller V. G., Jansen E., Lamb H. J., Baur L. H., van der Wall E. E., et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short‐axis MR images. J Comput Assist Tomogr 1997; 21: 756–65
   PubMed Web of Science ®Google Scholar
• Cerqueira M. D., Weissman N. J., Dilsizian V., Jacobs A. K., Kaul S., Laskey W. K., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539–42
   PubMed Web of Science ®Google Scholar
• Germano G., Berman D. S. Quantitative gated SPECT. J Nucl Med 2001; 42: 528–9
   PubMedGoogle Scholar
• Fuchs S., Kornowski R., Weisz G., Satler L. F., Smits P. C., Okubagzi P., et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 2006; 97: 823–9
   PubMed Web of Science ®Google Scholar
• Tse H. F., Thambar S., Kwong Y. L., Rowlings P., Bellamy G., McCrohon J., et al. Safety of catheter‐based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol 2006; 98: 60–2
   PubMedGoogle Scholar
• Briguori C., Reimers B., Sarais C., Napodano M., Pascotto P., Azzarello G., et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 2006; 151: 674–80
   PubMed Web of Science ®Google Scholar
• Mansour S., Vanderheyden M., De Bruyne B., Vandekerckhove B., Delrue L., Van Haute I., et al. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct‐related artery in patients with recent myocardial infarction. J Am Coll Cardiol 2006; 47: 1727–30
   PubMedGoogle Scholar
• Wollert K. C., Meyer G. P., Lotz J., Ringes‐Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone‐marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141–8
   PubMed Web of Science ®Google Scholar
• Assmus B., Walter D. H., Lehmann R., Honold J., Martin H., Dimmeler S., et al. Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur Heart J 2006; 27: 2989–95
   PubMedGoogle Scholar
• Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199–209
   PubMed Web of Science ®Google Scholar